A retrospective, observational, cohort study to evaluate treatment patterns and outcomes in patients with metastatic Non small cell lung cancer
Latest Information Update: 13 Jun 2017
At a glance
- Drugs Docetaxel (Primary) ; Erlotinib (Primary) ; Nivolumab (Primary) ; Pemetrexed (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 13 Jun 2017 New trial record
- 06 Jun 2017 Results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology